Centre for Endocrine Surgery, University College London Hospital and London Clinic, 250 Euston Road, London, NW1 2PG, UK.
Department of General Surgery, Alexandria University, Alexandria, Egypt.
J Endocrinol Invest. 2020 Sep;43(9):1205-1212. doi: 10.1007/s40618-020-01201-z. Epub 2020 Mar 2.
Intraoperative monitoring of parathyroid hormone (IOPTH) is a reliable method of predicting the cure of primary hyperparathyroidism (PHPT). The aim of this study is to assess whether common clinical variables (CCV) frequently encountered in patients with PHPT may affect the magnitude of PTH drop or the likelihood of patients meeting the intraoperative cure criterion.
Patients who were surgically cured from PHPT caused by single gland disease (SGD) and had full IOPTH protocol (4 measurements) were stratified according to age, gland weight, renal function, vitamin D status and severity of hypercalcemia. The percentage of IOPTH drop and the frequency of patients who had true positive IOPTH test results were compared among groups.
762 patients had surgery for PHPT, of whom 746 were (98%) cured. Of these 746 patients, 511 who had SGD and a full IOPTH protocol were included in this study. The median IOPTH drop was significantly higher among younger patients, those with severe hypercalcaemia at 5, 10, 15 min after gland excision, giant glands (at 5-min only), patients with vitamin D deficiency (at 10, 15 min), and those with normal renal function (at 15 min only). The likelihood of the patients meeting the intraoperative cure criterion was not significantly affected among the groups except in patients with mild hypercalcaemia, who were significantly less likely to have 50% IOPTH drop than those with severe hypercalcaemia at all time points. The frequency of mildly hypercalcaemic patients who met cure criterion was significantly improved by extending measurement to 15 min.
IOPTH monitoring has the ability to mitigate the variability of IOPTH kinetics associated with most clinical variables. Mildly hypercalcemic patients in particular may benefit from waiting for 15-min measurement before any surgical decision is made.
甲状旁腺激素(IOPTH)术中监测是预测原发性甲状旁腺功能亢进症(PHPT)治愈的可靠方法。本研究旨在评估 PHPT 患者常见的临床变量(CCV)是否可能影响 PTH 下降幅度或患者符合术中治愈标准的可能性。
根据年龄、腺体重量、肾功能、维生素 D 状态和高钙血症严重程度,对接受单腺疾病(SGD)手术且具有完整 IOPTH 方案(4 次测量)的 PHPT 患者进行分层。比较各组 IOPTH 下降百分比和具有真正阳性 IOPTH 检测结果的患者频率。
762 例患者因 PHPT 接受手术,其中 746 例(98%)治愈。在这 746 例患者中,511 例 SGD 患者和完整的 IOPTH 方案纳入本研究。在切除腺体后 5、10、15 分钟时,年轻患者、严重高钙血症患者、巨腺体患者(仅在 5 分钟时)、维生素 D 缺乏症患者(在 10、15 分钟时)和肾功能正常的患者(仅在 15 分钟时)的 IOPTH 下降幅度明显更高。除了轻度高钙血症患者外,各组患者符合术中治愈标准的可能性没有明显差异,与所有时间点严重高钙血症患者相比,他们发生 50% IOPTH 下降的可能性明显更低。通过将测量时间延长至 15 分钟,轻度高钙血症患者符合治愈标准的频率显著提高。
IOPTH 监测能够减轻与大多数临床变量相关的 IOPTH 动力学的可变性。特别是轻度高钙血症患者可能受益于在做出任何手术决定之前等待 15 分钟的测量。